Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T19:53:40.388Z.
Calculation as of: 2026-10-06T19:53:40.388Z.
Quote observation: 2026-10-06T19:50:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 833b8a33f5e3aa548e06775940c7a83493d9a3083fc648ecb3f8ecd80d633b38
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$238.57M
EV/EBIT Ratio
99.74x
TTM Avg
177.33x
3Y Avg
172.45x
5Y Avg
172.45x
Market Cap
$236.17M
EV/EBIT Ratio
N/A
TTM Avg
245.87x
3Y Avg
245.87x
5Y Avg
245.87x
Market Cap
$241.48M
EV/EBIT Ratio
N/A
TTM Avg
84.29x
3Y Avg
326.94x
5Y Avg
227.75x
Market Cap
$234.98M
EV/EBIT Ratio
22.89x
TTM Avg
12.07x
3Y Avg
10.11x
5Y Avg
11.81x
Market Cap
$234.90M
EV/EBIT Ratio
N/A
TTM Avg
5.15x
3Y Avg
5.03x
5Y Avg
6.70x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum-Si incorporated (QSI) | $238.38M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $238.57M | 99.74x | 177.33x | 172.45x | 172.45x |
| Century Therapeutics, Inc. (IPSC)vs › | $237.21M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $236.60M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.17M | N/A | 245.87x | 245.87x | 245.87x |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $241.48M | N/A | 84.29x | 326.94x | 227.75x |
| Q32 Bio Inc. (QTTB)vs › | $241.68M | 6.56x | 4.53x | 4.53x | 4.53x |
| Utah Medical Products, Inc. (UTMD)vs › | $234.98M | 22.89x | 12.07x | 10.11x | 11.81x |
| SIGA Technologies, Inc. (SIGA)vs › | $234.90M | N/A | 5.15x | 5.03x | 6.70x |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.12M | N/A | 98.16x | 1055.07x | 378.93x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
